Zhou SF - Search Results

1

Clinical association between pharmacogenomics and adverse drug reactions.

Zhou ZW, Chen XW, Sneed KB, Yang YX, Zhang X, He ZX, Chow K, Yang T, Duan W, Zhou SF. Zhou ZW, et al. Among authors: zhou sf. Drugs. 2015 Apr;75(6):589-631. doi: 10.1007/s40265-015-0375-0. Drugs. 2015. PMID: 25895462 Review.

2

Application of mechanism-based CYP inhibition for predicting drug-drug interactions.

Zhou ZW, Zhou SF. Zhou ZW, et al. Among authors: zhou sf. Expert Opin Drug Metab Toxicol. 2009 Jun;5(6):579-605. doi: 10.1517/17425250902926099. Expert Opin Drug Metab Toxicol. 2009. PMID: 19466877 Review.

3

Prediction of the likelihood of drug interactions with kinase inhibitors based on in vitro and computational studies.

Wang ZX, Sun J, Howell CE, Zhou QY, He ZX, Yang T, Chew H, Duan W, Zhou ZW, Kanwar JR, Zhou SF. Wang ZX, et al. Among authors: zhou qy, zhou zw, zhou sf. Fundam Clin Pharmacol. 2014 Oct;28(5):551-82. doi: 10.1111/fcp.12069. Epub 2014 Mar 21. Fundam Clin Pharmacol. 2014. PMID: 24612223

4

Estimation of the binding modes with important human cytochrome P450 enzymes, drug interaction potential, pharmacokinetics, and hepatotoxicity of ginger components using molecular docking, computational, and pharmacokinetic modeling studies.

Qiu JX, Zhou ZW, He ZX, Zhang X, Zhou SF, Zhu S. Qiu JX, et al. Among authors: zhou zw, zhou sf. Drug Des Devel Ther. 2015 Feb 16;9:841-66. doi: 10.2147/DDDT.S74669. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 25733806 Free PMC article.

5

Clinical pharmacology of dipeptidyl peptidase 4 inhibitors indicated for the treatment of type 2 diabetes mellitus.

Chen XW, He ZX, Zhou ZW, Yang T, Zhang X, Yang YX, Duan W, Zhou SF. Chen XW, et al. Among authors: zhou zw, zhou sf. Clin Exp Pharmacol Physiol. 2015 Oct;42(10):999-1024. doi: 10.1111/1440-1681.12455. Clin Exp Pharmacol Physiol. 2015. PMID: 26173919 Review.

6

An update on the clinical pharmacology of the dipeptidyl peptidase 4 inhibitor alogliptin used for the treatment of type 2 diabetes mellitus.

Chen XW, He ZX, Zhou ZW, Yang T, Zhang X, Yang YX, Duan W, Zhou SF. Chen XW, et al. Among authors: zhou zw, zhou sf. Clin Exp Pharmacol Physiol. 2015 Dec;42(12):1225-38. doi: 10.1111/1440-1681.12469. Clin Exp Pharmacol Physiol. 2015. PMID: 26218204 Review.

7

Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study.

Niu NK, Yin JJ, Yang YX, Wang ZL, Zhou ZW, He ZX, Chen XW, Zhang X, Duan W, Yang T, Zhou SF. Niu NK, et al. Among authors: zhou zw, zhou sf. Drug Des Devel Ther. 2015 Aug 7;9:4441-70. doi: 10.2147/DDDT.S79369. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26300629 Free PMC article.

8

Impact of physiological, pathological and environmental factors on the expression and activity of human cytochrome P450 2D6 and implications in precision medicine.

He ZX, Chen XW, Zhou ZW, Zhou SF. He ZX, et al. Among authors: zhou zw, zhou sf. Drug Metab Rev. 2015;47(4):470-519. doi: 10.3109/03602532.2015.1101131. Epub 2015 Nov 16. Drug Metab Rev. 2015. PMID: 26574146 Review.

9

A Comparison of Non-Human Primate Cytochrome P450 2D Members and the Implication in Drug Discovery.

He ZX, Chen XW, Yang Y, Zhou SF. He ZX, et al. Among authors: zhou sf. Curr Drug Metab. 2016;17(6):520-7. doi: 10.2174/1389200217666160219114241. Curr Drug Metab. 2016. PMID: 26892731 Review.

10

Herb-drug interactions: a literature review.

Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, Duan W, Koh HL, Zhou S. Hu Z, et al. Drugs. 2005;65(9):1239-82. doi: 10.2165/00003495-200565090-00005. Drugs. 2005. PMID: 15916450 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

447 results

Search Page